
Exagen XGN
$ 3.18
0.67%
Annual report 2025
added 03-10-2026
Exagen Historical Prices 2011-2026 | XGN
Annual Historical Prices Exagen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.25 | 3.25 | 1.77 | 2.36 | 7.6 | 18.3 | 17.1 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.3 | 1.77 | 7.66 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Bioventus
BVS
|
9.12 | $ 8.9 | 0.39 % | $ 593 M | ||
|
Brainsway Ltd.
BWAY
|
8.85 | $ 13.76 | 0.81 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 26.03 | 0.75 % | $ 723 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
65.4 | $ 68.22 | 2.83 % | $ 26.6 B | ||
|
Guardant Health
GH
|
107 | $ 87.75 | 0.66 % | $ 11 B | ||
|
Charles River Laboratories International
CRL
|
155 | $ 153.51 | 1.02 % | $ 7.61 B | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 17.49 | 0.98 % | $ 932 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
103 | $ 103.9 | 0.04 % | $ 19.6 B | ||
|
IQVIA Holdings
IQV
|
165 | $ 169.08 | 2.54 % | $ 29.1 B | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 15.52 | 3.81 % | $ 469 M | ||
|
Biodesix
BDSX
|
0.71 | $ 16.45 | -4.86 % | $ 2.13 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 100.08 | 2.53 % | $ 8.25 B | ||
|
Anixa Biosciences
ANIX
|
3.19 | $ 2.86 | 0.83 % | $ 92.8 K | ||
|
Danaher Corporation
DHR
|
210 | $ 194.79 | 1.77 % | $ 139 B | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Pacific Biosciences of California
PACB
|
1.66 | $ 1.41 | 3.68 % | $ 423 M | ||
|
Illumina
ILMN
|
103 | $ 122.27 | 2.51 % | $ 19.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 198.48 | -0.23 % | $ 22 B | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
139 | $ 113.6 | 1.58 % | $ 34.5 B | ||
|
BioNano Genomics
BNGO
|
2.79 | $ 1.12 | 0.9 % | $ 1.42 M | ||
|
DarioHealth Corp.
DRIO
|
1.53 | $ 9.28 | 10.24 % | $ 263 M | ||
|
NeoGenomics
NEO
|
11.6 | $ 8.32 | 0.97 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 9.24 | 1.43 % | $ 2 B | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 78.64 | 0.18 % | $ 5.31 B | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
1.19 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
449 | $ 454.41 | 0.17 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
1.38 K | $ 1 214.62 | 1.33 % | $ 25 B | ||
|
Celcuity
CELC
|
10.1 | $ 114.75 | -0.13 % | $ 4.53 B | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
14.1 | $ 17.68 | 1.61 % | $ 396 M | ||
|
Twist Bioscience Corporation
TWST
|
26.1 | $ 46.69 | 3.73 % | $ 2.79 B | ||
|
Invitae Corporation
NVTA
|
2.17 | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
53.9 | $ 199.75 | 1.05 % | $ 19.7 B |